KalVista Pharmaceuticals' Reverse Merger Round

KalVista Pharmaceuticals raised a round of funding on November 22, 2016.

KalVista Pharmaceuticals (NASDAQ: KALV) is a pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors as new treatments for diseases wit…

Articles about KalVista Pharmaceuticals' Reverse Merger Round: